Company profilePharmaceutical#178 of 1,318 in Pakistan✓ No DRAP alerts

Cunningham Pharmaceuticals (Pvt.) Ltd.

Pharmaceutical company · 99 brands · 68 molecules

99 registered products 47 pharmaceutical brands 68 distinct molecules 0 DRAP alerts

Company overview

99
registered products
47
pharmaceutical brands
68
distinct molecules
0
therapeutic classes
0
DRAP alerts

Cunningham Pharmaceuticals (Pvt.) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 99 product registrations across 68 distinct molecules. It is the 178th largest registrant in Pakistan by product count. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Cunningham

82 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

82
ceilings with an approval date
81
not revised in 2+ years
2024
oldest approval year
202481
20251
Longest without revision

Top molecules by brand count

Ceftriaxone8 brands
Rivaroxaban4 brands
Azithromycin4 brands
Cefixime4 brands
Cephalexin4 brands
Telmisartan4 brands
Tacrolimus3 brands
Aprepitant3 brands
Omeprazole3 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official113 products · Rs 36.3 – Rs 120,443.05
Median across source: Rs 462.35

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NEUTRO PHARMA (PVT) LTD. holds 101 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
Pharmasol (Pvt) Ltd. holds 87 molecules not in this portfolio
AcetazolamideAcyclovirAlpha KetoanaloguesAnastrazoleAnastrozoleAtracurium
NABIQASIM INDUSTRIES (PVT) LTD. holds 172 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir

Get the full profile for Cunningham

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.